Stepan Company Stock Earnings Reports

Stepan reported Q1 2026 results with mixed operational momentum amid a challenging macro and raw material environment. Organic net sales rose 4% year-over-year and organic volumes were broadly stable, with double-digit volume gains in Crop Productivity, Oilfield, Industrial Cleaning and Tier 2/3 customers. Adjusted EBITDA was $49.6 million (down 14% YoY) and adjusted net income was $10.3 million ($0.45/share), down 47% YoY. Reported net loss of $41.4 million ($1.81/share) reflects a $65.4 million pretax restructuring charge tied to site closures and decommissions; the cash impact in Q1 was minimal. Surfactants EBITDA declined due to lower absorption and production timing issues in Asia, a U.S. cold snap, competitive pressure in Mexico and elevated oleochemical costs; Polymers EBITDA increased 8% on North American strength; Specialty Products volumes grew 30% though EBITDA was slightly down on mix and raw material lag. Free cash flow was negative $14 million (typical Q1 working capital build); net debt was $511 million with leverage of 2.7x (improved vs. prior year). Project Catalyst (footprint, ops efficiency, organizational effectiveness) remains on track and is expected to deliver about $100 million pretax savings over two years (~60% in 2026). Management reiterated focus on ramping Pasadena, driving margin recovery in Surfactants, disciplined capital allocation (CapEx guide ~ $105–115M), deleveraging and maintaining dividends (quarterly dividend $0.395/share).